Preferred Name | riociguat | |
Synonyms |
methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate Adempas BAY 63-2521 Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate riociguat C20H19FN8O2 |
|
ID |
http://purl.obolibrary.org/obo/CHEBI_76018 |
|
Definition |
A carbamate ester that is the methyl ester of {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamic acid. It is used for treatment of chronic thromboembolic pulmonary hypertension and pulmonary arterial hypertension |
|
has role | ||
InChI |
InChI=1S/C20H19FN8O2/c1-28(20(30)31-2)15-16(22)25-18(26-17(15)23)14-12-7-5-9-24-19(12)29(27-14)10-11-6-3-4-8-13(11)21/h3-9H,10H2,1-2H3,(H4,22,23,25,26) |
|
InChIKey |
InChIKey=WXXSNCNJFUAIDG-UHFFFAOYSA-N |
|
label |
riociguat |
|
prefixIRI |
obo2:CHEBI_76018 |
|
prefLabel |
riociguat |
|
SMILES |
COC(=O)N(C)c1c(N)nc(nc1N)-c1nn(Cc2ccccc2F)c2ncccc12 |
|
Synonym |
methyl {4,6-diamino-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-5-yl}methylcarbamate Adempas BAY 63-2521 Methyl N-(4,6-diamino-2-{1-((2-fluorophenyl)methyl)-1H-pyrazolo(3,4-b)pyridin-3-yl}pyrimidin-5-yl)-N-methylcarbamate riociguat C20H19FN8O2 |
|
xref |
CiteXplore:PMC3363218 CiteXplore:22719060 CiteXplore:23883377 CiteXplore:23883383 Wikipedia:Riociguat CiteXplore:24015306 CiteXplore:23997048 CiteXplore:23775260 CiteXplore:20424448 ChEMBL:1480104 CiteXplore:22936711 CiteXplore:23883378 CiteXplore:23204120 KEGG DRUG:D09572 Patent:WO2007009607 CiteXplore:20801938 Reaxys:12581953 CiteXplore:23397304 CiteXplore:22900035 CiteXplore:21789188 CiteXplore:19129292 CiteXplore:23978639 Patent:US2009286781 CiteXplore:23963798 CiteXplore:24092345 Patent:WO2011147810 CiteXplore:23997053 CiteXplore:23939482 CiteXplore:22912874 CASRN:625115-55-1 CiteXplore:20956169 CiteXplore:21391889 |
|
subClassOf |